Lei Ye
Impact in
- Biomaterials top 1%
- Electrospun Nanofibers in Biomedical Applications
- Genetics top 2%
- Mesenchymal stem cell research
Papers in
-
- Pluripotent Stem Cells Research 20
- Congenital heart defects research 14
- Metabolism, Diabetes, and Cancer 14
- Angiogenesis and VEGF in Cancer 13
- Surgery 60
- Tissue Engineering and Regenerative Medicine 25
- Pancreatic function and diabetes 13
- Co-authors
- Jianyi Zhang (23 shared papers)Eugene K.W. Sim (22 shared papers)Husnain Kh Haider (21 shared papers)Yong Zhang (4 shared papers)Jianhua Ma (42 shared papers)Pengyuan Zhang (6 shared papers)Cory Swingen (4 shared papers)Jacqueline S. Wendel (4 shared papers)
- Journals
- Diabetes Therapy (7 papers)PLoS ONE (6 papers)Scientific Reports (6 papers)Medicine (5 papers)Circulation (5 papers)
- Partner nations
- ChinaSingaporeUnited States
In The Last Decade
Lei Ye
299 papers receiving 6.2k citations
Lei Ye's Hit Papers
Peers
Comparison fields: 5 of 173
- Biomaterials 711
- Genetics 468
- Molecular Biology 2.7k
- Surgery 1.6k
- Endocrinology, Diabetes and Metabolism 617
Countries citing papers authored by Lei Ye
This map shows the geographic impact of Lei Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Ye more than expected).
Fields of papers citing papers by Lei Ye
This network shows the impact of papers produced by Lei Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Ye. The network helps show where Lei Ye may publish in the future.
Co-authors
The 25 scholars most cited alongside Lei Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 319 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cardiac Repair in a Porcine Model of Acute Myocardial Infarction with Human Induced Pluripotent Stem Cell-Derived Cardiovascular Cells Hit paper breakdown → | 2014 | 353 |
| 2 | 2012 | 239 | |
| 3 | 2009 | 219 | |
| 4 | 2018 | 187 | |
| 5 | Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial Hit paper breakdown → | 2021 | 163 |
| 6 | 2009 | 129 | |
| 7 | 2018 | 116 | |
| 8 | 2018 | 104 | |
| 9 | 2013 | 103 | |
| 10 | 2019 | 93 | |
| 11 | 2017 | 91 | |
| 12 | 2015 | 82 | |
| 13 | 2011 | 76 | |
| 14 | 2013 | 76 | |
| 15 | 2012 | 74 | |
| 16 | 2009 | 74 | |
| 17 | 2007 | 74 | |
| 18 | 2015 | 73 | |
| 19 | 2017 | 70 | |
| 20 | 2013 | 67 |
About Lei Ye
Lei Ye is a scholar working on Molecular Biology, Surgery, Endocrinology, Diabetes and Metabolism, Genetics and Cancer Research, having authored 319 papers that have together received 6.2k indexed citations. Recurring topics across this work include Diabetes Management and Research (32 papers), Diabetes Treatment and Management (27 papers), Tissue Engineering and Regenerative Medicine (25 papers), Pluripotent Stem Cells Research (20 papers), Congenital heart defects research (14 papers), Metabolism, Diabetes, and Cancer (14 papers), Pancreatic function and diabetes (13 papers) and Angiogenesis and VEGF in Cancer (13 papers). The work is most often cited by research in Biomaterials (711 citations), Genetics (468 citations), Molecular Biology (2.7k citations), Surgery (1.6k citations) and Endocrinology, Diabetes and Metabolism (617 citations). Lei Ye has collaborated with scholars based in China, Singapore and United States. Frequent co-authors include Jianyi Zhang, Eugene K.W. Sim, Husnain Kh Haider, Yong Zhang, Jianhua Ma, Pengyuan Zhang, Cory Swingen, Jacqueline S. Wendel, Liping Su and Lora E. Burke. Their work appears in journals such as Diabetes Therapy, PLoS ONE, Scientific Reports, Medicine and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.